Ledger.Open graph →
SEC Form D · filed July 31, 2019

ENDRA Life Sciences Inc

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Rafi Syed · San Carlos, CADirectorJohn Fay · New York, NYExec · DirectorTheodore Blosser · San Carlos, CADirectorEugene Lee · San Carlos, CAExecAndrew Zbella · New York, NYExecArshdeep Mand · San Carlos, CADirectorAlexander Y. Tokman · Ann Arbor, MIDirectorAndrew Adams · Atlanta, GADirectorRobert G. Bearden, Jr · Atlanta, GADirectorRebecca Parekh · New York, NYDirectorSarrah Hallock · New York, NYDirectorKane Sarhan · New York, NYExecLiza Landsman · New York, NYExecAnne-Cecile Vasseur-Jourdren · Luxembourg-Findel, LuxembourgExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗